L. A. Naess, S. C. Christiansen, P. Romundstad, S. C. Cannegieter, F. R. Rosendaal et al., Incidence and mortality of venous thrombosis : a population-based study, J Thromb Haemost, vol.5, issue.4, pp.692-701, 2007.

A. Nicolaides, K. Breddin, P. Carpentier, S. Coccheri, J. Conard et al., Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence), Int Angiol, vol.25, issue.2, pp.101-61, 2006.

S. Bouée, C. Emery, A. Samson, J. Gourmelen, C. Bailly et al., Incidence of venous thromboembolism in France : a retrospective analysis of a national insurance claims database, Thrombosis J, vol.14, p.4, 2016.

E. Oger, Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale, Thromb Haemost, vol.83, issue.5, pp.657-60, 2000.
URL : https://hal.archives-ouvertes.fr/hal-00726218

, HAS -Service évaluation économique et santé publique. Dépistage systématique de la thrombophilie avant une primo-prescription de contraception hormonale combinée, 2015.

, Avril, 2020.

A. T. Cohen, G. Agnelli, F. A. Anderson, J. I. Arcelus, D. Berggvist et al., Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality, Thromb Haemost, vol.98, pp.756-764, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00688301

R. J. Mcmanus, D. A. Fitzmaurice, M. E. , and T. C. Thromboemboslim, BMJ Clin Evid, vol.8, p.208, 2011.

S. Kachroo, D. Boyd, B. K. Bookhart, J. Lamori, J. R. Schein et al., Quality of life and economic costs associated with postthrombotic syndrome, Am J Health Syst Pharm, vol.69, issue.7, pp.567-72, 2012.

, Items 224 & 326. Embolie pulmonaire et thrombose veineuse profonde. Prescription et surveillance des antithrombotiques, 2015.

L. Quéhé-p-&-bressollette, examen écho-doppler veineux des membres inférieurs » Dans Echographie-doppler vasculaire. PU François Rabelais, pp.3-10, 2017.

L. E. Flinterman, A. Van-hylckama-vlieg, S. C. Cannegieter, and F. R. Rosendaal, Long-term survival in a large cohort of patients with venous thrombosis : incidence and predictors, PLoS Med, issue.9, 2012.

A. S. Wolberg, F. R. Rosendaal, J. I. Weitz, I. H. Jaffer, G. Agnelli et al., Venous thrombosis, Nat Rev Dis Primers, vol.1, p.15006, 2015.

R. Virchow, Gesammalte Abhandlungen zur Wissenschattlichen Medizin, Medlinger Sohn &co, p.1856

P. H. Reistma, H. H. Versteeg, and S. Middeldorp, Mechanistic view of risk factors for venous thromboembolism, Arterioscler. Thrombomb. Vasc. Biol, vol.32, pp.563-568, 2012.

S. Sevitt, The structure and growth of valve-pocket thrombi in femoral veins, J Clin Pathol, vol.27, issue.7, pp.517-528, 1974.

T. W. Wakefield, D. D. Myers, and P. K. Henke, Mechanisms of venous thrombosis and resolution, Arterioscler Thromb Vasc Biol, vol.28, pp.387-391, 2008.

T. W. Wakefield and P. K. Henke, The role of inflammation in early and late venous thrombosis : are there clinical implications ?, Semin Vasc Surg, vol.18, pp.118-129, 2005.

B. F. Becker, B. Heindl, C. Kupatt, and S. Zahler, Endothelial function and hemostasis, Zeitschrift Fur Kardiologie, vol.89, pp.160-167, 2000.

J. Zhou, L. May, and P. Liao, Inferior vena cava ligation rapidly induces tissue factor expression and venous thrombosis in rats, Arterioscler Thromb Vasc Biol, vol.29, issue.6, pp.863-869, 2009.

V. Brühl, M. L. Stark, K. Steinhart, A. Chandraratne, S. et al., Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo, J Exp Med, vol.209, issue.4, pp.819-835, 2012.

J. A. Diaz, S. K. Wrobleski, C. M. Alvarado, A. E. Hawley, N. K. Doombos et al., Pselectin inhibition therapeutically promotes thrombus resolution and prevents vein wall fibrosis better than enoxaparin and an inhibitor to von Willebrand factor, Arterioscler Thromb Vasc Biol, vol.35, issue.4, pp.829-837, 2015.

E. Ramacciotti, D. D. Myers, S. Wrobleski, K. B. Deatrick, and F. J. Londy, P-selectin/PSGL-1 inhibitors versus enoxaparin in the resolution of venous thrombosis : a meta-analysis, Thromb Res, vol.125, issue.4, pp.138-142, 2010.

M. J. Eppihimer and R. G. Schaub, P-selectin-dependent inhibition of thrombosis during venous stasis, Arterioscler Thromb Vasc Biol, vol.20, pp.2483-2488, 2000.

B. Engelmann and S. Massberg, Thrombosis as an intravascular effector of innate immunity, Nat Rev Immunol, vol.13, pp.34-45, 2013.

A. S. Savchenko, K. Martinod, and M. A. Seidman, Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development, J Thrombos Haemost, vol.12, issue.6, pp.860-870, 2014.

C. Schulz, B. Engelmann, and S. Massberg, Crossroads of coagulation and innate immunity : the case of deep vein thrombosis, J Thromb Haemost, vol.11, pp.233-274, 2013.

T. A. Fuchs, A. Brill, and D. Duerschmied, Extracellular DNA traps promote thrombosis, Proc Natl Acad Sci USA, vol.107, issue.36, pp.15880-15885, 2010.

J. R. Byrnes and A. S. Wolberg, New findings on venous thrombogenesis, Hemost, vol.37, pp.25-35, 2017.

L. A. Castelluci, Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism : systemic review and network meta-analysis, BMJ, vol.347, p.5133, 2013.

J. Riedl and C. Pabinger-i-&-ay, Platelets in cancer and thrombosis, Hamostaseologie, vol.34, issue.1, pp.54-62, 2014.

R. Marchioli, G. Finazzi, and G. Specchia, CYTO-PV Collaborative Group. Cardiovascular events and intensity of treatment in polycythemia vera, N Engl J Med, vol.368, issue.1, pp.22-33, 2013.

S. K. Braekkan, E. B. Mathiesen, I. Njolstad, T. Wilsgaard, and J. B. Hansen, Hematocrit and risk of venous thromboembolism in a general population. The Tromso study, Haematologica, vol.95, issue.2, pp.270-275, 2010.

L. Eischer, V. Tscholl, G. Heinze, L. Traby, P. A. Kyrle et al., Hematocrit and the risk of recurrent venous thrombosis : a prospective cohort study, PLoS One, vol.7, issue.6, p.38705, 2012.

J. L. Spivak, Polycythemia vera : myths, mechanisms, and management, Blood, vol.100, issue.13, pp.4272-4290, 2002.

H. C. Kwaan and J. Wang, Hyperviscosiy in polycythemia vera and other red cell abdomalities, Semin Thromb Hemost, vol.29, issue.5, pp.451-458, 2003.

O. K. Baskurt and H. J. Melselman, Blood rheology and hemodynamics, Semin Thromb Hemost, vol.29, pp.435-450, 2003.

M. D. Cappellini, L. Robbiolo, B. M. Bottasso, R. Coppola, G. Fiorelli et al., Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia, Br J Haematol, vol.111, issue.2, pp.467-473, 2000.

R. F. Schilling, R. E. Gangnon, and M. I. Traver, Delayed adverse vascular events after splenectomy in hereditary spherocytosis, J Thromb Haemost, vol.6, issue.8, pp.1289-1295, 2008.

R. P. Rother, L. Bell, P. Hillmen, and M. T. Gladwin, The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin : a novel mechanism of human disease, JAMA, vol.293, issue.13, pp.1653-1662, 2005.

M. T. Santos, J. Valles, and A. J. Marcus, Enhancement of platelet eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment, J Clin Invest, vol.87, issue.2, pp.571-580, 1991.

V. Peyrou, J. C. Lormeau, J. P. Hérault, C. Gaich, A. M. Pfliegger et al., Contribution of erythrocytes to thrombin generation in whole blood, Thromb Haemost, vol.81, issue.3, pp.400-406, 1999.

M. F. Whelihan, V. Zachary, T. Orfeo, and K. G. Mann, Prothrombin activation in blood coagulation : the erythrocyte contribution to thrombin generation, Blood. 2012. Nov, vol.1, issue.18, pp.3837-3882

P. E. Van-der-meijden, M. Van-schilfgaarde, R. Van-oerle, T. Renné, C. H. Ten et al., Platelet-and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa, J Thromb Haemost, vol.10, issue.7, pp.1355-1362, 2012.

L. Holley, N. Woodland, W. T. Hung, C. K. Reuben, and A. , Influence of fibrinogen and haematocrit on erythrocyte sedimentation kinetics, Biorheology, vol.36, issue.4, pp.287-297, 1999.

M. W. Rampling, The binding of fibrinogen and fibrinoen degradation products to the erythrocyte membrane and its relationship to haemorheology, Acta Biol Med Ger, vol.40, issue.4-5, pp.373-378, 1981.

M. M. Aleman, J. R. Byrnes, J. G. Wang, R. Tran, W. A. Lam et al., FactorXIII activity mediates red blood cell retention in venous thrombi, J Clin Invest, vol.124, issue.8, pp.3590-3600, 2014.

S. A. Smith, R. J. Travers, and J. H. Morrissey, How it all starts : initiation of the clotting cascade, Crit Rev Biochem Mol Biol, vol.50, issue.4, pp.326-336, 2015.

S. M. Day, J. L. Reeve, and B. Pedersen, Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall, Blood, vol.105, issue.1, pp.192-198, 2005.

L. A. Killewich, G. R. Bedford, K. W. Beach, and D. E. Strandness, Spontaneous lysis of deep venous thrombi : rate and outcome, J Vasc Surg, vol.9, pp.89-97, 1989.

A. Chandrashekar, J. Garry, A. Gasparis, and N. Labropoulos, Vein wall remodeling in patients with acute deep vein thrombosis and chronic postthrombotic changes, J Thromb Haemost, vol.15, pp.1989-93, 2017.

G. J. Stewart, Neutrophils and deep vein thrombosis, Haemostasis, vol.23, issue.1, pp.127-140, 1993.

. Ansm, Recommandations de bonne pratique : prévention et traitement de la maladie thromboembolique veineuse en médecine, 2009.

I. Quéré, A. Elias, M. Maufus, M. Elias, M. A. Sevestre et al., Unresolved questions on venous thromboembolic disease. Consensus statement of the French Society for Vascular Medecine (SFMV), J Med Vasc, vol.44, pp.1-47, 2019.

C. Kearon, E. A. Akl, J. Ornelas, A. Blaivas, D. Jimenez et al., CHEST, vol.149, issue.2, pp.315-352, 2016.

G. Agnelli, C. Becattini, G. Meyer, A. Muñoz, M. V. Huisman et al., Apixaban for the treatment of venous thromboembolism associated with cancer, N Engl J Med, vol.382, issue.17, pp.1599-1607, 2020.

S. R. Kahn, S. Shapiro, and P. S. Wells, Compression stockings to prevent post-thrombotic syndrome : a randomised placebo-controlled trial, Lancet, vol.383, issue.9920, pp.880-888, 2014.

C. N. Wang and H. R. Deng, Percutaneous endovenous intervention plus anticoagulatin versus anticoagulation alone for treating patients with proximal deep vein thrombosis : a meta-analysis and systematic review, Ann Vasc Surg, vol.49, pp.39-48, 2018.

P. C. Wong, Y. C. Chan, Y. Law, and S. Cheng, Percutaneous mechanical thrombectomy in the treatment of acute iliofemoral deep vein thrombosis : a systemic review, Hong Kong Med J, vol.25, pp.48-57, 2019.

S. Vedantham, S. Z. Goldhaber, J. A. Julian, S. R. Kahn, M. R. Jaff et al., Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis, N Engl J Med, vol.377, issue.23, pp.2240-2252, 2017.

A. S. Nathan and J. Giri, Reexamining the open-vein hypothesis for acute deep venous thrombosis, Circulation, vol.139, pp.1174-1180, 2019.

P. O. Hansson, J. Sorbo, and H. Eriksson, Recurrent venous thromboembolism after deep vein thrombosis. Incidence and risk factors, Arch Intern Med, vol.160, pp.769-774, 2000.

P. Prandoni, A. W. Lensing, and M. H. Prins, Below-knee elastic compression stockings to prevent the post-thrombotic syndrome : a randomized, controlled trial, Annals of Internal Medecine, vol.141, issue.4, pp.249-256, 2004.

S. R. Kahn, A. J. Comerota, and M. Cushman, The Postthrombotic syndrome evidence-based prevention, diagnosis and treatment strategies : a scientific statement from the, American Heart Association. Circulation, vol.130, issue.18, pp.1636-1661, 2014.

J. P. Galanaud, M. Righini, L. Collen, L. Douillard, A. Robert-ebadi et al., Long-term risk of postthrombotic syndrome after symptomatic distal deep vein thrombosis: The CACTUS-PTS study, J Thromb Haemost, 2020.

J. P. Galanaud, M. Righini, L. Collen, L. Douillard, A. Robert-ebadi et al., Long-term risk of postthrombotic syndrome after symptomatic distal deep vein thrombosis : the CACTUS-PTS study, J Thromb Haemost, vol.18, issue.4, pp.857-864, 2020.

M. R. Jaff, M. S. Mcmurtry, S. L. Archer, M. Cushman, and N. Goldenberg, Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension : a scientific statement from the american heart association, Circulation, vol.123, pp.1788-1830, 2011.

P. Vaisseaux-du-membre-inférieur-;-kamina, D. Marino, V. Francke, J. P. Santini, J. J. et al., Anatomie Clinique -Membres -Tome, vol.1, pp.508-513, 2009.

S. R. Kahn, S. Desmarais, T. Ducruet, L. Arsenault, and J. S. Ginsberg, Comparison of the Villalta and Ginsberg clinical scales to diagnose the post-thrombotic syndrome : correlation with patient-reported disease burden and venous valvular reflux, J Thromb Haemost, vol.4, pp.907-908, 2006.

A. Leizorovicz, Long-term consequences of deep vein thrombosis, Haemostasis, vol.28, issue.3, pp.1-7, 1998.

S. R. Kahn, How i treat posthrombotic syndrome, Blood, vol.114, issue.21, pp.4624-4631, 2009.

G. V. Belcaro, U. Hofmann, and A. Bollinger, Laser doppler. London : Med-Orion, 1994.

S. R. Kahn, H. Partsch, S. Vedantham, P. Prandoni, and C. Kearon, Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of post-thrombotic syndrome of the leg for use in clinical investigations : a recommendation for standardization, J Thromb Haemost, vol.7, pp.879-883, 2009.

M. Perrin, J. L. Gillet, and J. J. Guex, Syndrome post-thrombotique, Angéiologie, p.12, 2003.

D. P. Brandjes, H. R. Buller, and H. Heijboer, Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis, Lancet, vol.349, issue.9054, pp.759-762, 1997.

J. S. Ginsberg, J. Hirsh, J. Julian, D. Magier, B. Mackinnon et al., Prevention and treatment of postphlebitic syndrome. Results of a 3-part study, Arch Intern Med, vol.161, pp.2105-2109, 2001.

S. Villalta, P. Bagatella, A. Piccioli, A. Lensing, M. H. Prins et al., Assessment of validity and reproductibility of a clinical scale for the post-thrombotic syndrome, Haemostasis, vol.24, p.158, 1994.

S. R. Kahn, A. Hirsch, and I. Shrier, Effect of post-thrombotic syndrome on health-related quality of life after deep venous thrombosis, Arch Intern Med, vol.162, pp.1144-1148, 2002.

S. R. Kahn, H. Shbaklo, D. L. Lamping, C. A. Holcroft, I. Shrier et al., Determinants of health-related quality of life during the 2 years following deep vein thrombosis, J Thromb Haemost, vol.6, pp.1105-1112, 2008.

S. R. Kahn, Measurements properties of the Villalta scales to define and classify the severity of the post-thrombotic syndrome, Journal of Thrombosis and Haemostasis : JTH, vol.7, issue.5, pp.884-888, 2009.

K. K. Utne, W. Ghanima, S. Foyn, S. R. Kahn, P. M. Sandset et al., Development and validation of a tool for patient reporting of symptoms and signs of the post-thrombotic syndrome, Thromb Harmost, vol.115, pp.361-368, 2016.

M. Engeseth, T. Enden, M. Sandset, P. Skuterud, and W. , Limitations of the Villalta scale in diagnosing post-thrombotic syndrome, Thrombosis Research, vol.184, pp.62-66, 2019.

A. M. O'shaugnessy and D. E. Fitzgerald, The patterns and distribution of residual abormalities between the individuel proximal venous segments after an acute deep vein thrombosis, J Vasc Surg, vol.33, pp.379-384, 2001.

V. Bharath, S. R. Kahn, and A. Lazo-langner, Genetic polymorphisms of vein wall remodeling in chronic venous disease : a narrative and systemic review, Blood, vol.124, issue.8, pp.1242-1250, 2014.

R. Kurstjens, M. De-wolf, J. Van-laanen, and M. W. De-haan, Hemodynamic significance of collateral blood flow in chronic venous obstruction, Phlebology, vol.30, issue.15, pp.27-34, 2015.

P. Neglen and S. Raju, Balloon dilatation and stenting of chronic iliac vein obstruction : technical aspects and early clinical outcome, J Endovasc Ther, vol.7, pp.79-91, 2000.

S. R. Kahn, J. P. Galanaud, S. Vedantham, and J. S. Ginsberg, Guidance for the prevention and treatment of the post-thrombotic syndrome, J thromb Thrombolysis, vol.41, pp.144-153, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01881981

A. Rabinovich, T. Ducruet, S. R. Kahn, S. Shapiro, V. Tagalakis et al., Development of a clinical prediction model for the posthrombotic syndrome in a prospective cohort of patients with proximal deep vein thrombosis, J Thromb Haemost, vol.16, pp.262-270, 2018.

B. Cucuruz, R. Kopp, K. Pfister, and J. Noppeney, Risk and protective factors for postthrombotic syndrome after deep venous thrombosis, J Vasc Surg : Venous and Lymp Dis, pp.1-6, 2019.

J. P. Galanaud, M. Monreal, and S. R. Kahn, Epidemiology of the post-thrombotic syndrome, Thromb Res, vol.164, pp.100-109, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02332346

S. Schulman, P. Lindmarker, M. Holmstrom, G. Larfars, and A. Carlsson, Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months, J Thromb Haemost, vol.4, pp.734-776, 2006.

J. R. Padberg, M. V. Johnson, and S. A. Sisto, Structured exercise improves calf muscle pump function in chronic venous insufficiency : a randomized trial, J Vasc Surg, vol.39, issue.1, pp.79-87, 2004.

S. R. Kahn, I. Shrier, S. Shapiro, and A. H. Houweling, Six-month exercise training program to treat post-thrombotic syndrome : a randomized controlled two-centre trial, CMAJ, vol.183, issue.1, pp.37-44, 2011.

A. Rabinovich, C. S. Gu, S. Vedantham, C. Kearon, S. Z. Goldhaber et al., ATTRACT trial investigators. External validation of the SOX-PTS score in a prospective multicenter trial of patients with proximal deep vein thrombosis, J Thromb Haemost, vol.18, issue.6, pp.1381-1389, 2020.

I. Makedonov, S. R. Kahn, and J. P. Galanaud, Prevention and Management of the postthrombotic syndrome, J Clin Med, vol.9, issue.4, p.923, 2020.

T. F. O'donnell, M. A. Passman, W. A. Marston, W. J. Ennis, M. Dalsing et al., Management of venous leg ulcers : Clinical practice guidelines of the society for vascular surgery and the American venous forum, J Vasc Surg, vol.60, pp.3-59, 2014.

W. Ghanima, H. S. Wik, M. Tavoly, T. Enden, and J. Lp, Late consequences of venous thromboembolism : measuring quality of life after deep vein thrombosis and pulmonary embolism, Thrombosis research, vol.164, pp.170-176, 2018.

B. K. Lal, Venous ulcers of the lower extremity : definition, epidemiology, and economic and social burdens. Seminar in vascular surgery, vol.28, pp.3-5, 2015.

O. Hartung, P. Barthelemy, M. Boufi, and Y. Alimi, Traitement endovasculaire des lésions obstructives ilio-caves post-thrombotiques, Phlébologie, vol.62, pp.54-59, 2009.

R. Launois, Health-related quality-of-life scales specific for chronic venous disorders of the lower limbs, J Vasc Surg : Venous and Lym Dis, vol.3, pp.219-246, 2015.

M. Wolf, R. De-graaf, R. Kurstjens, S. Penninx, H. Jalaie et al., Shortterm clinical experience with a dedicated venous nitinol stent : initial results with the sinusvenous stent, Eur J Vasc Endovasc Surg, vol.50, pp.518-526, 2015.

R. Warren and T. R. Thayer, Transplantation of the saphenous vein for post-phlebitic stasis, Surgery, vol.35, pp.867-878, 1954.

R. Danza, T. Navarro, and J. Baldizan, Reconstructive surgery in chronic venous obstruction of the lower limbs, J Cardiovasc Surg (Torino), vol.32, pp.98-103, 1991.

D. M. Coleman, J. E. Rectenwald, F. C. Vandy, and T. W. Wakefield, Contemporary results after sapheno-popliteal bypass for chronic femoral vein occlusion, J Vasc Surg Venous Lymphat Disord, vol.1, pp.45-51, 2013.

P. Ec and R. Esperon, Vein transplants and grafts in the surgical treatment of the postphlebitic syndrome, J Cardiovasc (Torino), vol.1, pp.94-107, 1960.

N. Garg, P. Gloviczki, K. M. Karimi, A. A. Duncan, H. Bjarnason et al., Factors affecting outcome of open and hybrid reconstructions for non malignant obstruction of iliofemoral veins ans inferior vena cava, J Vasc Surg, vol.53, pp.383-393, 2011.

M. L. Avila, M. Montoya, C. Lumia, and A. Marson, Compression stockings to prevent post-thrombotic syndrome in adults, a Bayesian meta-analysis, Thromb Research, vol.182, pp.20-26, 2019.

S. Azirar, D. Appelen, M. H. Prins, and M. H. Neumann, Compression therapy for treating post-thrombotic syndrome, Cochrane Database Syst Rev, vol.9, p.4177, 2019.

G. C. Mol, M. A. Van-de-ree, F. A. Klok, M. Tegelberg, F. Sanders et al., One versus two years of elastic compression stockings for prevention of post-thrombotic syndrome (OCTAVIA study): Randomised controlled trial, BMJ, vol.353, p.2691, 2016.

A. J. Ten-cate-hoek, E. E. Amin, A. C. Bouman, K. Meijer, L. W. Tick et al., Individualised versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome (IDEAL DVT): A multicentre, randomised, single-blind, allocation-concealed, non-inferiority trial, Lancet Haematol, vol.5, pp.25-33, 2018.

P. Prandoni, F. Noventa, R. Quintavalla, C. Bova, B. Cosmi et al., Thigh-length versus below-knee compression elastic stockings for prevention of the post-thrombotic syndrome in patients with proximal-venous thrombosis: A randomized trial, Blood, vol.119, pp.1561-156, 2012.

C. Bradbury, K. Fletcher, Y. Sun, C. Heneghan, C. Gardiner et al., A randomised controlled trial of extended anticoagulation treatment versus standard treatment for the prevention of recurrent venous thromboembolism (VTE) and post-thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (the ExACT study), Br. J. Haematol, vol.188, issue.6, pp.962-975, 2020.

R. S. Chitsike, M. A. Rodger, M. J. Kovacs, M. T. Betancourt, P. S. Wells et al., Risk of post-thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study, J Thromb Haemost, vol.10, issue.10, pp.2039-2083, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00724644

R. Carter, K. Talbot, W. S. Hur, S. C. Meixner, J. G. Van-der-gugten et al., Rivaroxaban and apixaban induce clotting factor Xa fibrinolytic activity, J Thromb Haemost, vol.16, issue.11, pp.2276-2288, 2018.

Y. W. Cheung, S. Middeldorp, M. H. Prins, A. F. Pap, A. Lensing et al., Post-thrombotic syndrome in patients treated with rivaroxaban or enoxaparin/vitamin K antagonists for acute deepvein thrombosis, Thromb. Haemost, vol.116, pp.733-738, 2016.

K. K. Utne, A. Dahm, H. S. Wik, L. P. Jelsness-jorgensen, P. M. Sanset et al., Rivaroxaban versus warfarin for the prevention of post-thrombotic syndrome, Thrombosis Research, vol.163, pp.6-11, 2018.

P. K. Piati, A. K. Peres, D. O. Andrade, M. A. Jorge, and J. F. Toregeani, Analysis of recanalization of deep venous thrombosis :a comparative study of patients treated with warfarin vs. rivaroxaban, J Vasc Bras, vol.18, p.20180111, 2019.

C. B. Newman, D. Preiss, J. A. Tobert, T. A. Jacobson, R. L. Page et al., on behalf of the american heart association clinical lipidology, lipoprpotein, metabolism and thrombosis committe, a joint committe of the council on atherosclerosis, thrombosis and vascular biology and council on lifestyle and cardiometabolix health, council on cardiovascular disease in the young ; council clinical cardiology ; and stroke council. Statin safety and associated adverse events, Arterioscler Thromb vasc biol, vol.39, issue.2, pp.38-81, 2019.

P. Pierre-rochcongar-avec-le-collège and . De, Aptitude au sport chez les adultes et l'enfant : besoins nutritionnels chez le sportif, Nutrition. Item, vol.253, 2016.

H. Partsch, M. Kaulich, and W. Mayer, Immediate mobilisation in acute vein thrombosis reduces post-thromboticsyndrome, Int. Angiol, vol.23, pp.206-212, 2004.

T. Enden, Y. Haig, N. E. Klow, C. E. Slagsvold, L. Sandvik et al., Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study) : a randomised controlled trial, Lancet, vol.379, issue.9810, pp.31-38, 2012.

Y. Haig, T. Enden, O. Grotta, N. E. Klow, C. E. Slagsvold et al., Postthrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT) : 5-year follow-up results of an open-label, randomised controlled trial, Lancet Haematol, vol.3, pp.64-71, 2016.

L. Watson, C. Broderick, and M. P. Amon, Thrombolysis for acute deep vein thrombosis, Cochrane Database Syst Rev, vol.11, p.2783, 2016.

M. Thomas, A. Hollingsworth, and R. Mofidi, Endovascular Management of acute lower limb deep vein thrombosis : a systemic review and meta-analysis, Ann Vasc Surg, vol.58, pp.363-70, 2019.

G. C. Du, M. C. Zhang, and J. C. Zhao, Catheter-directed thrombolysis plus anticoagulation versus anticoagulation alone in the treatment of proximal deep vein thrombosis -a systemic meta-analysis, Vasa, vol.44, pp.195-202, 2015.

G. Eckenrode, B. B. Nelson, A. Belarmino, S. A. Chen, S. Goel et al., Meta-analysis and systematic review of interventional therapy versus anticoagulation for isolated femoropopliteal deep venous thrombosis, J of Vasc Surg : Venous and Lym Dis, vol.7, pp.272-278, 2019.

A. Rabinovich, J. M. Cohen, M. Cushman, S. R. Kahn, and B. Investigators, Association between inflammation biomarkers, anatomic extent of deep venous thrombosis, and venous symptoms after deep venous thrombosis, J Vasc Surg Venous Lymphat Disord, vol.3, pp.347-53, 2015.

A. Rabinovich, J. M. Cohen, M. Cushman, P. S. Wells, M. A. Rodger et al., Inflammation markers and their trajectories after deep vein thrombosis in relation to risk of post-thrombotic syndrome, J Thromb Haemost, vol.13, pp.398-408, 2015.

J. R. Byrnes and A. S. Wolberg, Red blood cells in thrombosis, Blood, vol.130, issue.16, pp.1795-1799, 2017.

J. R. Byrnes, C. Duval, and Y. Wang, Factor XIIIa-dependent retention of red blood cells in clots is mediated by fibrin ?-chain crosslinking, Blood, vol.126, issue.16, pp.1940-1948, 2015.

B. Jacqueline and «. Virchow-rudolf--, 1821-1902) », Encyclopaedia Universalis

. Einstein-investigators, R. Bauersachs, S. D. Berkowitz, B. Brenner, H. R. Buller et al., Oral rivaroxaban for symptomatic venous thromboembolism, N Engl J Med, vol.363, issue.26, pp.2499-510, 2010.

S. Schulman, C. Kearon, A. K. Kakkar, P. Mismetti, S. Schellong et al., Dabigatran versus warfarin in the treatment of acite venous tromboemboslim, N Engl J Med, vol.361, pp.2342-52, 2009.

G. Agnelli, H. R. Buller, A. Cohen, M. Curto, A. S. Gallus et al., Oral apixaban for the treatment of acute venous thromboembolism, N Engl J Med. 2013, vol.369, issue.9, pp.799-808
URL : https://hal.archives-ouvertes.fr/hal-00932477

-. Hokusai, . Investigators, H. R. Büller, H. Décousus, M. A. Grosso et al., Edoxban versus warfarin for the treatment of symptomatic venous thromboembolism, N Engl J Med, vol.369, issue.15, pp.1406-1421, 2013.

. Serment-d'hippocrate,

, Au moment d'être admise à exercer la médecine, je promets et je jure d'être fidèle aux lois de l'honneur et de la probité

, Mon premier souci sera de rétablir, de préserver ou de promouvoir la santé dans tous ses éléments, physiques et mentaux, individuels et sociaux

, Je respecterai toutes les personnes, leur autonomie et leur volonté, sans aucune discrimination selon leur état ou leurs convictions. J'interviendrai pour les protéger si elles sont affaiblies, vulnérables ou menacées dans leur intégrité ou leur dignité. Même sous la contrainte

, Je ne tromperai jamais leur confiance et n'exploiterai pas le pouvoir hérité des circonstances pour forcer les consciences

, Je ne me laisserai pas influencer par la soif du gain ou la recherche de la gloire

, Admise dans l'intimité des personnes, je tairai les secrets qui me seront confiés. Reçue à l'intérieur des maisons, je respecterai les secrets des foyers et ma conduite ne servira pas à corrompre les moeurs

, Je ne prolongerai pas abusivement les agonies. Je ne provoquerai jamais la mort délibérément

, Je n'entreprendrai rien qui dépasse mes compétences. Je les entretiendrai et les perfectionnerai pour assurer au mieux les services qui me seront demandés

, J'apporterai mon aide à mes confrères ainsi qu'à leurs familles dans l'adversité

, Que les hommes et mes confrères m'accordent leur estime si je suis fidèle à mes promesses; que je sois déshonorée et méprisée si j'y manque